Welcome!

News Feed Item

Coronary Thrombosis Global Clinical Trials Review, H2, 2014

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Coronary Thrombosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/652973/Coronary-Thrombosis-Global-Clinical-Trials-Review-H2-2014.html

Coronary Thrombosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Coronary Thrombosis Global Clinical Trials Review, H2, 2014" provides data on the Coronary Thrombosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Thrombosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Thrombosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

List of Tables 3
List of Figures 4
Introduction 5
Coronary Thrombosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Coronary Thrombosis 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Drugs 23
Clinical Trial Overview of Top Institutes / Government 24
Hopital de la Timone 24
Clinical Trial Overview of Hopital de la Timone 24
Fujian Provincial Hospital 25
Clinical Trial Overview of Fujian Provincial Hospital 25
Herz-Zentrum Bad Krozingen 26
Clinical Trial Overview of Herz-Zentrum Bad Krozingen 26
University of Zurich 27
Clinical Trial Overview of University of Zurich 27
NHS Greater Glasgow and Clyde 28
Clinical Trial Overview of NHS Greater Glasgow and Clyde 28
Samsung Medical Center 29
Clinical Trial Overview of Samsung Medical Center 29
Hamilton Health Sciences 30
Clinical Trial Overview of Hamilton Health Sciences 30
Odense University Hospital 31
Clinical Trial Overview of Odense University Hospital 31
Universitaire Ziekenhuizen Leuven 32
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven 32
Assistance Publique - Hopitaux de Paris 33
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 33
Five Key Clinical Profiles 34
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Disclaimer 53
Source 53

List of Tables
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Coronary Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Coronary Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Coronary Thrombosis Therapeutics, Global, Terminated Clinical Trials, 2014* 20
Coronary Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 22
Coronary Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 23
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital de la Timone, 2014* 24
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fujian Provincial Hospital, 2014* 25
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Herz-Zentrum Bad Krozingen, 2014* 26
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2014* 27
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Greater Glasgow and Clyde, 2014* 28
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014* 29
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014* 30
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 31
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014* 32
Coronary Thrombosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 33

List of Figures
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Coronary Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Coronary Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Coronary Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 12
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Coronary Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Coronary Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 15
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Coronary Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Coronary Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Coronary Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 21
Coronary Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 22
GlobalData Methodology 52

Read the full report:
Coronary Thrombosis Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/652973/Coronary-Thrombosis-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"My role is working with customers, helping them go through this digital transformation. I spend a lot of time talking to banks, big industries, manufacturers working through how they are integrating and transforming their IT platforms and moving them forward," explained William Morrish, General Manager Product Sales at Interoute, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
More and more companies are looking to microservices as an architectural pattern for breaking apart applications into more manageable pieces so that agile teams can deliver new features quicker and more effectively. What this pattern has done more than anything to date is spark organizational transformations, setting the foundation for future application development. In practice, however, there are a number of considerations to make that go beyond simply “build, ship, and run,” which changes ho...
The Internet of Things can drive efficiency for airlines and airports. In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect with GE, and Sudip Majumder, senior director of development at Oracle, will discuss the technical details of the connected airline baggage and related social media solutions. These IoT applications will enhance travelers' journey experience and drive efficiency for the airlines and the airports. The session will include a working demo and a technical d...
Kubernetes is a new and revolutionary open-sourced system for managing containers across multiple hosts in a cluster. Ansible is a simple IT automation tool for just about any requirement for reproducible environments. In his session at @DevOpsSummit at 18th Cloud Expo, Patrick Galbraith, a principal engineer at HPE, discussed how to build a fully functional Kubernetes cluster on a number of virtual machines or bare-metal hosts. Also included will be a brief demonstration of running a Galera M...
Why do your mobile transformations need to happen today? Mobile is the strategy that enterprise transformation centers on to drive customer engagement. In his general session at @ThingsExpo, Roger Woods, Director, Mobile Product & Strategy – Adobe Marketing Cloud, covered key IoT and mobile trends that are forcing mobile transformation, key components of a solid mobile strategy and explored how brands are effectively driving mobile change throughout the enterprise.
Developing software for the Internet of Things (IoT) comes with its own set of challenges. Security, privacy, and unified standards are a few key issues. In addition, each IoT product is comprised of (at least) three separate application components: the software embedded in the device, the back-end service, and the mobile application for the end user’s controls. Each component is developed by a different team, using different technologies and practices, and deployed to a different stack/target –...
Identity is in everything and customers are looking to their providers to ensure the security of their identities, transactions and data. With the increased reliance on cloud-based services, service providers must build security and trust into their offerings, adding value to customers and improving the user experience. Making identity, security and privacy easy for customers provides a unique advantage over the competition.
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of So...
SYS-CON Events announced today that Commvault, a global leader in enterprise data protection and information management, has been named “Bronze Sponsor” of SYS-CON's 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Commvault is a leading provider of data protection and information management solutions, helping companies worldwide activate their data to drive more value and business insight and to transform moder...
SYS-CON Events announced today that eCube Systems, a leading provider of middleware modernization, integration, and management solutions, will exhibit at @DevOpsSummit at 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. eCube Systems offers a family of middleware evolution products and services that maximize return on technology investment by leveraging existing technical equity to meet evolving business needs. ...
SYS-CON Events has announced today that Roger Strukhoff has been named conference chair of Cloud Expo and @ThingsExpo 2016 Silicon Valley. The 19th Cloud Expo and 6th @ThingsExpo will take place on November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. "The Internet of Things brings trillions of dollars of opportunity to developers and enterprise IT, no matter how you measure it," stated Roger Strukhoff. "More importantly, it leverages the power of devices and the Interne...
Personalization has long been the holy grail of marketing. Simply stated, communicate the most relevant offer to the right person and you will increase sales. To achieve this, you must understand the individual. Consequently, digital marketers developed many ways to gather and leverage customer information to deliver targeted experiences. In his session at @ThingsExpo, Lou Casal, Founder and Principal Consultant at Practicala, discussed how the Internet of Things (IoT) has accelerated our abil...
Digital innovation is the next big wave of business transformation based on digital technologies of which IoT and Big Data are key components, For example: Business boundary innovation is a challenge to excavate third-party business value using IoT and BigData, like Nest Business structure innovation may propose re-building business structure from scratch, as Uber does in the taxicab industry The social model innovation is also a big challenge to the new social architecture with the design fr...
Whether they’re located in a public, private, or hybrid cloud environment, cloud technologies are constantly evolving. While the innovation is exciting, the end mission of delivering business value and rapidly producing incremental product features is paramount. In his session at @DevOpsSummit at 19th Cloud Expo, Kiran Chitturi, CTO Architect at Sungard AS, will discuss DevOps culture, its evolution of frameworks and technologies, and how it is achieving maturity. He will also cover various st...
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, provided tips on how to be successful in large scale machine learning...